Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07362979
What this trial is testing

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 243
Not applicableNot Yet RecruitingNCT07578727
What this trial is testing

A Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Guangzhou Concord Cancer Center 504
Testing effectiveness (Phase 2)Study completedNCT05918224
What this trial is testing

Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 160
Testing effectiveness (Phase 2)Study completedNCT04929080
What this trial is testing

The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC

Who this might be right for
Head and Neck Squamous Cell CarcinomNasopharyngeal Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 149
Testing effectiveness (Phase 2)Looking for participantsNCT06093061
What this trial is testing

Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
National Cancer Centre, Singapore 53
Large-scale testing (Phase 3)UnknownNCT02610010
What this trial is testing

Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 462
Not applicableStudy completedNCT05292027
What this trial is testing

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 84
Testing effectiveness (Phase 2)UnknownNCT04220528
What this trial is testing

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 129
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06892431
What this trial is testing

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Who this might be right for
Recurrent or Metastatic Nasopharyngeal CancerPatients Who Have Experienced Treatment Failure at Least Second-line Chemotherapy
Shanghai JMT-Bio Inc. 150
Large-scale testing (Phase 3)Looking for participantsNCT07311772
What this trial is testing

Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Radiation-induced Oral Mucositis
Sun Yat-sen University 386
Large-scale testing (Phase 3)Study completedNCT05564286
What this trial is testing

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Who this might be right for
Cervical CancerNasopharyngeal CancerChemotherapy-induced Nausea and Vomiting+2 more
Shantou University Medical College 116
Testing effectiveness (Phase 2)Study completedNCT01094405
What this trial is testing

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Who this might be right for
Nasopharyngeal CancerEpstein-Barr Virus Infections
Chinese University of Hong Kong 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07794488
What this trial is testing

Platinum-Free Regimen in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Zhejiang Cancer Hospital 145
Testing effectiveness (Phase 2)UnknownNCT00003856
What this trial is testing

Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy

Who this might be right for
Head and Neck Cancer
Quintiles, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT01469429
What this trial is testing

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage 0 Hypopharyngeal Cancer+55 more
Ohio State University Comprehensive Cancer Center 70
Early research (Phase 1)Study completedNCT03474640
What this trial is testing

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Who this might be right for
Advanced Malignancies
TopAlliance Biosciences 184
Testing effectiveness (Phase 2)Study completedNCT01534585
What this trial is testing

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Taizhou Hospital 48
Not applicableUnknownNCT03093649
What this trial is testing

Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 320
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07388758
What this trial is testing

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 37
Not applicableUnknownNCT04158518
What this trial is testing

De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chaosu Hu 118
Next Page